BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 24, 2005
View Archived Issues
Antipsychotic effects of a new 5-HT2C receptor agonist from Pfizer
Read More
Curcumin and its metabolite highlighted as promising agents for neurologic disorders
Read More
JNJ-27291199, an Hdm2:p53 complex inhibitor, potentiates doxorubicin
Read More
NSC-67657: A CEBPalpha activator with antileukemic potential
Read More
Tanabe updates pipeline progress in H1 FY2005
Read More
Oscient files Factive sNDA for five-day treatment of new indications
Read More
Pfizer exercises option to NicOx collaborative compounds
Read More
Myriad Genetics and Abbott extend pharmacogenetics alliance
Read More
First patient enrolled in European phase III trial of Alzhemed
Read More
Large multivalent immunogen vaccine active in melanoma, renal cell carcinoma
Read More
Tocilizumab study results reveal efficacy in arthritis, systemic lupus erythematosus
Read More
Golimumab improves signs and symptoms of refractory rheumatoid arthritis
Read More
Oral cFMS kinase inhibitor GW-2580 inhibits CSF-1 signaling in vivo
Read More
ALK5 inhibition attenuates profibrotic signaling and fibrogenic response
Read More
Flow-induced arterial remodeling modified by cavtratin
Read More
Novartis reports novel CCR1 antagonists with activity in experimental arthritis
Read More
Clevudine demonstrates sustained activity in chronic hepatitis B patients
Read More
Lassa fever vaccine candidate developed
Read More
ENMD-1198 to enter clinical testing in 2006
Read More
Emergent BioSolutions tests single dose oral typhoid vaccine in Vietnam
Read More
Genzyme acquires Cell Genesys' San Diego manufacturing operation
Read More
Phase IIb HCV study to evaluate celgosivir plus Pegetron
Read More
ChemoCentryx seeks clearance to begin clinical studies of CCX-915
Read More
Enrollment begins in phase III Viprinex study for ischemic stroke
Read More
Phase III Oxytrex results in moderate to severe osteoarthritic pain
Read More
Allergan proposes to acquire Inamed
Read More
Xyrem approved to treat excessive daytime sleepiness in narcolepsy patients
Read More
Approvable letter for Vasovist
Read More
Pexelizumab fails to meet primary endpoint threshold for statistical significance
Read More
Recent Merck KGaA patent claims novel anticoagulant agents
Read More
Cardiovascular agents disclosed in recent patent literature
Read More